Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment

Journal of Infection

Volumn 60, Issue 2, 2010, Pages 114-121

  Van Nieuwkoop, C ^a   van't Wout, J W ^a,b   Spelt, I C ^c   Becker, M ^b   Kuijper, E J ^a   Blom, J W ^a   Assendelft, W J J ^a   van Dissel, J T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c Primary Health Care Center   (Netherlands)

Author keywords

Acute pyelonephritis; Complicated UTI; Home based treatment; Primary care; Urinary tract infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN;

ACUTE PYELONEPHRITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG TREATMENT FAILURE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTPATIENT CARE; PATIENT REFERRAL; PATIENT SAFETY; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SEPSIS; SURVIVAL RATE; SURVIVAL TIME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; FEMALE; HEALTH SERVICES RESEARCH; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYELONEPHRITIS; TREATMENT OUTCOME;

EID: 75549087450     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.11.008     Document Type: Article

References (38)

1. Brown P., Ki M., Foxman B. Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 2005, 23(11):1123-1142.
2. Nicolle L.E., Friesen D., Harding G.K., Roos L.L. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 1996, 22(6):1051-1056.
3. Foxman B., Klemstine K.L., Brown P.D. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality. Ann Epidemiol 2003, 13(2):144-150.
4. Safrin S., Siegel D., Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med 1988, 85(6):793-798.
5. Ward G., Jorden R.C., Severance H.W. Treatment of pyelonephritis in an observation unit. Ann Emerg Med 1991, 20(3):258-261.
6. Israel R.S., Lowenstein S.R., Marx J.A., Koziol-McLain J., Svoboda L., Ranniger S. Management of acute pyelonephritis in an emergency department observation unit. Ann Emerg Med 1991, 20(3):253-257.
7. Pinson A.G., Philbrick J.T., Lindbeck G.H., Schorling J.B. ED management of acute pyelonephritis in women: a cohort study. Am J Emerg Med 1994, 12(3):271-278.
8. Mombelli G., Pezzoli R., Pinoja-Lutz G., Monotti R., Marone C., Franciolli M. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999, 159(1):53-58.
9. Talan D.A., Stamm W.E., Hooton T.M., Moran G.J., Burke T., Iravani A., et al. Comparison of ciprofloxacin (7days) and trimethoprim-sulfamethoxazole (14days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000, 283(12):1583-1590.
10. Klausner H.A., Brown P., Peterson J., Kaul S., Khashab M., Fisher A.C., et al. A trial of levofloxacin 750mg once daily for 5days versus ciprofloxacin 400mg and/or 500mg twice daily for 10days in the treatment of acute pyelonephritis. Curr Med Res Opin 2007, 23(11):2637-2645.
11. Warren J.W., Abrutyn E., Hebel J.R., Johnson J.R., Schaeffer A.J., Stamm W.E. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999, 29(4):745-758.
12. Hooton T.M. The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003, 17(2):303-332.
13. Ramakrishnan K., Scheid D.C. Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician 2005, 71(5):933-942.
14. ACOG Practice Bulletin No.91 Treatment of urinary tract infections in nonpregnant women. Obstet Gynecol 2008, 111(3):785-794.
15. Grabe M, Bishop MC, Bjerklund-Johansen TE, Botto H, Cek M, Lobel B, et al. Guideline on urological infections. European Association of Urology. Accessed at on 21 April 2009. http://www.uroweb.org/nc/professional-resources/guidelines/online.
16. Neal D.E.J. Complicated urinary tract infections. Urol Clin North Am 2008, 35(1):13-22.
17. Acute pyelonephritis. NHS Clinical Knowledge Summaries. Accessed at on 7 October 2009. http://www.cks.nhs.uk/pyelonephritis_acute.
18. Pinson A.G., Philbrick J.T., Lindbeck G.H., Schorling J.B. Fever in the clinical diagnosis of acute pyelonephritis. Am J Emerg Med 1997, 15(2):148-151.
19. Piccoli G.B., Consiglio V., Colla L., Mesiano P., Magnano A., Burdese M., et al. Antibiotic treatment for acute 'uncomplicated' or 'primary' pyelonephritis: a systematic, 'semantic revision'. Int J Antimicrob Agents 2006, 28(Suppl 1):S49-S63.
20. van Haaren K.A.M., Visser H.S., van Vliet S., Timmermans A.E., Yadava R., Geerlings S.E., et al. NHG-Standaard Urineweginfecties: tweede herziening [Guideline of the Dutch College of General Practitioners on urinary tract infections: second revision]. Huisarts Wet 2005, 48:341-352.
21. Kunin C.M. Definition of acute pyelonephritis vs the urosepsis syndrome. Arch Intern Med 2003, 163(19):2393-2394.
22. Hoogendoorn M., van 't Wout J.W., Schijf V., van Dissel J.T. Predictive value of chills in patients presenting with fever to urgent care department. Ned Tijdschr Geneeskd 2002, 146(3):116-120.
23. Nicolle L.E. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008, 35(1):1-12. v.
24. Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 1992, 15(Suppl 1):S216-S227. S216-27.
25. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101(6):1644-1655.
26. Lever A., Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ 2007, 335(7625):879-883.
27. Ong D.S., Kuyvenhoven M.M., van D.L., Verheij T.J. Antibiotics for respiratory, ear and urinary tract disorders and consistency among GPs. J Antimicrob Chemother 2008, 62(3):587-592.
28. Harmsen M., Wensing M., Braspenning J.C., Wolters R.J., van der Wouden J.C., Grol R.P. Management of children's urinary tract infections in Dutch family practice: a cohort study. BMC Fam Pract 2007, 8:9.
29. Elkharrat D., Chastang C., Boudiaf M., Le Corre A., Raskine L., Caulin C. Relevance in the emergency department of a decisional algorithm for outpatient care of women with acute pyelonephritis. Eur J Emerg Med 1999, 6(1):15-20.
30. Claessens Y.E., Schmidt J., Batard E., Grabar S., Jegou D., Hausfater P., et al. Can C-reactive protein, procalcitonin and mid-regional pro-atrial natriuretic peptide measurements guide choice of in-patient or out-patient care in acute pyelonephritis? Biomarkers In Sepsis (BIS) multicentre study. Clin Microbiol Infect 2009.
31. Talan D.A., Krishnadasan A., Abrahamian F.M., Stamm W.E., Moran G.J. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008, 47(9):1150-1158.
32. Hooton T.M., Scholes D., Gupta K., Stapleton A.E., Roberts P.L., Stamm W.E. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005, 293(8):949-955.
33. Stolper E., van B.M., Houben P., Van R.P., van de W.M., van der W.T., et al. The diagnostic role of gut feelings in general practice. A focus group study of the concept and its determinants. BMC Fam Pract 2009, 10:17.
34. van Langevelde P., Joop K., van Loon J., Frolich M., Groeneveld P.H., Westendorp R.G., et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 2000, 31(6):1343-1348.
35. van Dissel J.T., Numan S.C., Van't Wout J.W. Chills in 'early sepsis': good for you?. J Intern Med 2005, 257(5):469-472.
36. Tal S., Guller V., Levi S., Bardenstein R., Berger D., Gurevich I., et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect 2005, 50(4):296-305.
37. Hsu C.Y., Fang H.C., Chou K.J., Chen C.L., Lee P.T., Chung H.M. The clinical impact of bacteremia in complicated acute pyelonephritis. Am J Med Sci 2006, 332(4):175-180.
38. Efstathiou S.P., Pefanis A.V., Tsioulos D.I., Zacharos I.D., Tsiakou A.G., Mitromaras A.G., et al. Acute pyelonephritis in adults: prediction of mortality and failure of treatment. Arch Intern Med 2003, 163(10):1206-1212.